NEW YORK, May 12, 2023 /PRNewswire/ — Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Relmada Therapeutics, Inc. (NYSE: RLMD) To be contacted by a member of our team, fill out the form: https://claimyourloss.com/securities/relmada-class-action-loss-submission-form/?from=4 Further details on the investigation: Before…Read More
RLMD FRAUD ALERT Jakubowitz Law is Investigating Relmada Therapeutics Inc in Connection with Potential Violations of Federal Securities Laws MarketScreener
